Annie Pardo Selected Research

Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)

1/2022	Single Nucleotide Polymorphisms (SNP) and SNP-SNP Interactions of the Surfactant Protein Genes Are Associated With Idiopathic Pulmonary Fibrosis in a Mexican Study Group; Comparison With Hypersensitivity Pneumonitis.
6/2021	Development of a Diagnostic Biosensor Method of Hypersensitivity Pneumonitis towards a Point-of-Care Biosensor.
1/2020	SNP and Haplotype Interaction Models Reveal Association of Surfactant Protein Gene Polymorphisms With Hypersensitivity Pneumonitis of Mexican Population.
1/2020	Identification of Autophagy-related Proteins in Lungs From Hypersensitivity Pneumonitis Patients.
1/2020	Hypersensitivity pneumonitis.
1/2019	PINK1 attenuates mtDNA release in alveolar epithelial cells and TLR9 mediated profibrotic responses.
2/2015	Fibrocytes contribute to inflammation and fibrosis in chronic hypersensitivity pneumonitis through paracrine effects.
1/2011	Immunoglobulin free light chains are increased in hypersensitivity pneumonitis and idiopathic pulmonary fibrosis.
7/2010	PDCD1 gene polymorphisms in different Mexican ethnic groups and their role in the susceptibility to hypersensitivity pneumonitis.
4/2008	Transporter associated with antigen processing (TAP) 1 gene polymorphisms in patients with hypersensitivity pneumonitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annie Pardo Research Topics

Disease

35	Fibrosis (Cirrhosis) 01/2022 - 03/2003
30	Idiopathic Pulmonary Fibrosis 01/2022 - 04/2002
20	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2021 - 03/2002
12	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2022 - 01/2006
9	Inflammation (Inflammations) 12/2021 - 01/2002
8	Lung Injury 01/2019 - 03/2003
6	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020 - 01/2006
6	Lung Diseases (Lung Disease) 01/2019 - 08/2013
4	Pneumonia (Pneumonitis) 11/2015 - 05/2003
2	Mitochondrial Diseases (Mitochondrial Disease) 07/2021 - 11/2017
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 01/2017
2	Bronchiectasis 10/2017 - 08/2012
2	Disease Progression 04/2015 - 05/2010
2	Neoplasms (Cancer) 08/2013 - 03/2007
2	Cicatrix (Scar) 12/2011 - 06/2006
2	Carcinogenesis 11/2008 - 03/2007
1	Starvation 12/2016
1	Hyperplasia 10/2016
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 03/2014
1	Wounds and Injuries (Trauma) 09/2013
1	Lung Neoplasms (Lung Cancer) 08/2013
1	Glioma (Gliomas) 12/2012
1	Asymptomatic Infections 11/2011
1	Infections 11/2011

Drug/Important Bio-Agent (IBA)

23	Bleomycin (Blenoxane)FDA LinkGeneric 03/2021 - 04/2002
8	AntigensIBA 06/2021 - 07/2007
8	Metalloproteases (Metalloproteinases)IBA 01/2021 - 04/2002
7	CollagenIBA 01/2017 - 08/2005
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2008
6	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 05/2003
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2008
5	Biological ProductsIBA 01/2021 - 02/2015
4	MicroRNAs (MicroRNA)IBA 12/2021 - 07/2010
4	indium-bleomycinIBA 01/2018 - 03/2003
3	Surface-Active Agents (Surfactants)IBA 01/2022 - 04/2015
3	Mitochondrial DNA (mtDNA)IBA 01/2020 - 01/2017
3	EnzymesIBA 01/2020 - 03/2003
3	CytokinesIBA 01/2019 - 08/2002
3	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2015 - 02/2012
3	OligonucleotidesIBA 01/2006 - 03/2002
2	AsbestosIBA 01/2020 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2008
2	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 04/2015
2	Ephrin-B2 (Ephrin B2)IBA 12/2017 - 12/2017
2	IntegrinsIBA 01/2017 - 09/2011
2	Pharmaceutical PreparationsIBA 01/2017 - 01/2016
2	Therapeutic UsesIBA 10/2016 - 11/2011
2	lysophosphatidic acidIBA 01/2016 - 01/2008
2	Hydroxyproline (4 Hydroxyproline)IBA 11/2015 - 05/2013
2	Matrix Metalloproteinase 7 (Matrilysin)IBA 04/2012 - 04/2002
2	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 02/2004 - 11/2003
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2003 - 03/2003
2	SmokeIBA 10/2003 - 05/2003
1	Mitochondrial Permeability Transition PoreIBA 07/2021
1	1-aminopropenal acetic acidIBA 06/2021
1	AntibodiesIBA 06/2021
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 03/2021
1	8-hydroxyguanineIBA 01/2020
1	Oxidants (Oxidizing Agents)IBA 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020
1	TensinsIBA 01/2020
1	Autophagy-Related ProteinsIBA 01/2020
1	DNA Glycosylases (DNA Glycosylase)IBA 01/2020
1	Matrix Metalloproteinase 13IBA 01/2019
1	TunicamycinIBA 08/2018
1	Serine Proteases (Serine Protease)IBA 01/2018
1	Fibrillar CollagensIBA 01/2018
1	DisintegrinsIBA 12/2017
1	Sirtuin 3IBA 01/2017
1	Extracellular Matrix ProteinsIBA 01/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2016
1	Sirolimus (Rapamycin)FDA Link 12/2016
1	PP242IBA 12/2016
1	Fibroblast Growth Factor 1 (FGF-1)IBA 10/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2016
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2016
1	AerosolsIBA 11/2015
1	Annexin A5IBA 11/2015
1	Mitogen-Activated Protein KinasesIBA 11/2015
1	Cre recombinaseIBA 04/2015
1	Laminin (Merosin)IBA 04/2015
1	Protein CIBA 04/2015
1	matrix metalloproteinase 19IBA 03/2015
1	Dehydroepiandrosterone (DHEA)IBA 11/2013
1	StaurosporineIBA 09/2013
1	telomerase RNA (bTR)IBA 08/2013
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 08/2013
1	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2013
1	Transcription Factors (Transcription Factor)IBA 12/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2012
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 08/2012
1	Bortezomib (Velcade)FDA Link 02/2012
1	Proteasome InhibitorsIBA 02/2012
1	Immunomodulating AgentsIBA 11/2011
1	ChemokinesIBA 11/2011
1	Interleukin-6 (Interleukin 6)IBA 11/2011

Therapy/Procedure

5	Therapeutics 11/2017 - 01/2002
2	Traction 10/2017 - 08/2012